Literature DB >> 26344329

Subacute Hypoxia-Ischemia and the Timing of Injury in Treatment With Therapeutic Hypothermia.

Ericalyn Kasdorf1, Amos Grunebaum2, Jeffrey M Perlman3.   

Abstract

OBJECTIVE: This study aims to categorize infants treated with therapeutic hypothermia who presented with suspected subacute hypoxia-ischemia-that is, injury that likely occurred well before delivery and thus beyond the 6-hour window for therapeutic hypothermia-and to contrast the clinical characteristics with infants who suffered a known acute hypoxia-ischemia event.
DESIGN: A retrospective chart review was undertaken of infants treated with therapeutic hypothermia at our center during a 6-year period. Suspected subacute injury is defined as decreased fetal movement greater than 6 hours before delivery or severe depression at birth without need for cardiopulmonary resuscitation. Acute injury is defined as an acute perinatal event including placental abruption, ruptured uterus, or umbilical cord abnormalities. Abnormal outcome is defined as death, cognitive delay, or spastic quadriplegia at follow-up.
RESULTS: Infants with subacute (n = 7) versus acute injury (n = 26) were less likely to require cardiopulmonary resuscitation, were less acidotic at birth on cord gases with no significant difference in initial postnatal pH or base deficit, were more severely encephalopathic with severe amplitude electroencephalogram suppression, and demonstrated universal adverse outcome.
CONCLUSIONS: These data demonstrate greater benefit of therapeutic hypothermia for those infants with acute versus subacute injury. Early initiation of therapeutic hypothermia relative to the presumed onset of hypoxia-ischemia is critical. Early severe encephalopathy in the absence of a known acute perinatal event should raise concern in some cases for a subacute insult where the effect of therapeutic hypothermia is unlikely to be of benefit.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cerebral hypoxia-ischemia; hypothermia; induced; infant; newborn

Mesh:

Year:  2015        PMID: 26344329     DOI: 10.1016/j.pediatrneurol.2015.07.012

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  2 in total

Review 1.  Leveraging the interplay of nanotechnology and neuroscience: Designing new avenues for treating central nervous system disorders.

Authors:  Elizabeth S Smith; Joshua E Porterfield; Rangaramanujam M Kannan
Journal:  Adv Drug Deliv Rev       Date:  2019-03-04       Impact factor: 15.470

2.  Diffusion pseudonormalization and clinical outcome in term neonates with hypoxic-ischemic encephalopathy.

Authors:  Katsumi Hayakawa; Sachiko Koshino; Koichi Tanda; Akira Nishimura; Osamu Sato; Hiroyuki Morishita; Takaaki Ito
Journal:  Pediatr Radiol       Date:  2018-02-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.